Humacyte Inc (HUMA)

$1.58 +0.04 (2.60%)
Market Cap 245.09M
Revenue (ttm) 0.00
Net Income (ttm) -148.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,577,800
Avg Vol 4,606,766
Day's Range N/A - N/A
Shares Out 155.12M
Stochastic %K 19%
Beta 1.90
Analysts Strong Sell
Price Target $9.25

Company Profile

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It...

Industry: Biotechnology
Sector: Healthcare
Phone: 919 313 9633
Address:
2525 East North Carolina Highway 54, Durham, United States
GJ_Rockabilt
GJ_Rockabilt Aug. 23 at 4:47 PM
$HUMA My heart tells me to Buy. However, my brain says STAY OUT, for a while. You know the rule.
0 · Reply
cdaviscamera
cdaviscamera Aug. 23 at 5:10 AM
$HUMA all eyes on V007. 👀
1 · Reply
Doctor_C_MD
Doctor_C_MD Aug. 23 at 4:07 AM
$HUMA I would say Zack's is trash, but that would be an insult to trash.
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Aug. 23 at 3:34 AM
$HUMA https://finance.yahoo.com/news/worth-investing-humacyte-inc-huma-133002295.html
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Aug. 23 at 3:33 AM
$HUMA It's kinda nice to know I Sold at a loss, before Zack's Artificial Intelligence came up with a Sell recommendation.
0 · Reply
Doctor_C_MD
Doctor_C_MD Aug. 23 at 1:51 AM
$HUMA Think about it...In 3 years this is the first time I have seen repeated negative articles coming out from places like "Newser" & "Timothysykes.net". If you google "Humacyte", three of the first articles (all negative) redirect you to a link to join a whatsapp group. This...combined with all these brand new bears, who just appeared for the first time points to likely manipulative short activity.
1 · Reply
Doctor_C_MD
Doctor_C_MD Aug. 23 at 1:47 AM
$HUMA Just a word of caution. I have been invested in this stock for nearly 3 years. I check this board routinely. Of all the people posting bearish posts and panicking over the last 1-2 weeks. This is the first time I have seen 90% of them in 3 years. Most likely that a majority of them are paid stock bashers.
0 · Reply
JuniperLuna
JuniperLuna Aug. 22 at 7:06 PM
$HUMA I recommend Laura divorce Dougan. Just a suggestion. NFA.
1 · Reply
Akwaba76
Akwaba76 Aug. 22 at 5:29 PM
$HUMA you don't need shorters when you got someone like Doug in the BOD
1 · Reply
paulN98
paulN98 Aug. 22 at 4:54 PM
$HUMA so sad, this stock was trading at 1.75-1.80 post earnings and was literally on its way back to 2 until dougy dumped
1 · Reply
Latest News on HUMA
Humacyte: Cash Burn And A Glacial Launch Overshadow VAC Progress

Aug 12, 2025, 1:20 PM EDT - 11 days ago

Humacyte: Cash Burn And A Glacial Launch Overshadow VAC Progress

Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 10:00 AM EDT - 12 days ago

Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript

Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update

Aug 11, 2025, 7:00 AM EDT - 12 days ago

Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025

Aug 7, 2025, 8:00 AM EDT - 16 days ago

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025

Humacyte Announces First Symvess™ Sale to Military Treatment Facility

Jul 23, 2025, 8:00 AM EDT - 4 weeks ago

Humacyte Announces First Symvess™ Sale to Military Treatment Facility

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency

Jul 8, 2025, 8:00 AM EDT - 6 weeks ago

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency

Humacyte: Revenue Ramp From Symvess Incoming

Jun 11, 2025, 9:05 AM EDT - 2 months ago

Humacyte: Revenue Ramp From Symvess Incoming

Results from Humacyte's V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting

Jun 9, 2025, 8:00 AM EDT - 2 months ago

Results from Humacyte's V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting

Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3

Jun 2, 2025, 8:00 AM EDT - 2 months ago

Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3

Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq

May 19, 2025, 4:05 PM EDT - 3 months ago

Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq

Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript

May 13, 2025, 2:29 PM EDT - 3 months ago

Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript

Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update

May 13, 2025, 7:30 AM EDT - 3 months ago

Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

May 9, 2025, 8:00 AM EDT - 3 months ago

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript

Mar 28, 2025, 1:48 PM EDT - 5 months ago

Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript

Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

Mar 28, 2025, 7:30 AM EDT - 5 months ago

Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

Mar 26, 2025, 8:00 AM EDT - 5 months ago

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

Mar 25, 2025, 8:35 PM EDT - 5 months ago

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

Mar 25, 2025, 4:01 PM EDT - 5 months ago

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics

Mar 10, 2025, 8:00 AM EDT - 5 months ago

Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics

Trestle Bio Announces Research Collaboration with Humacyte

Mar 6, 2025, 8:00 AM EST - 6 months ago

Trestle Bio Announces Research Collaboration with Humacyte

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025

Mar 3, 2025, 8:00 AM EST - 6 months ago

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025

Humacyte to Present at the TD Cowen 45th Annual Health Care Conference

Feb 27, 2025, 4:05 PM EST - 6 months ago

Humacyte to Present at the TD Cowen 45th Annual Health Care Conference

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues

Feb 27, 2025, 8:00 AM EST - 6 months ago

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues

Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

Feb 26, 2025, 8:00 AM EST - 6 months ago

Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

Humacyte, Inc. - Investors of Humacyte Stock Encouraged to Contact Kehoe Law Firm, P.C. - HUMA

Feb 20, 2025, 1:35 PM EST - 6 months ago

Humacyte, Inc. - Investors of Humacyte Stock Encouraged to Contact Kehoe Law Firm, P.C. - HUMA

Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting

Jan 21, 2025, 8:00 AM EST - 7 months ago

Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting

HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Jan 17, 2025, 10:30 AM EST - 7 months ago

HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Investors in Humacyte, Inc. Should Contact The Gross Law Firm Before January 17, 2025 to Discuss Your Rights - HUMA

Jan 9, 2025, 5:45 AM EST - 8 months ago

Investors in Humacyte, Inc. Should Contact The Gross Law Firm Before January 17, 2025 to Discuss Your Rights - HUMA

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Jan 2, 2025, 8:15 AM EST - 8 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

GJ_Rockabilt
GJ_Rockabilt Aug. 23 at 4:47 PM
$HUMA My heart tells me to Buy. However, my brain says STAY OUT, for a while. You know the rule.
0 · Reply
cdaviscamera
cdaviscamera Aug. 23 at 5:10 AM
$HUMA all eyes on V007. 👀
1 · Reply
Doctor_C_MD
Doctor_C_MD Aug. 23 at 4:07 AM
$HUMA I would say Zack's is trash, but that would be an insult to trash.
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Aug. 23 at 3:34 AM
$HUMA https://finance.yahoo.com/news/worth-investing-humacyte-inc-huma-133002295.html
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Aug. 23 at 3:33 AM
$HUMA It's kinda nice to know I Sold at a loss, before Zack's Artificial Intelligence came up with a Sell recommendation.
0 · Reply
Doctor_C_MD
Doctor_C_MD Aug. 23 at 1:51 AM
$HUMA Think about it...In 3 years this is the first time I have seen repeated negative articles coming out from places like "Newser" & "Timothysykes.net". If you google "Humacyte", three of the first articles (all negative) redirect you to a link to join a whatsapp group. This...combined with all these brand new bears, who just appeared for the first time points to likely manipulative short activity.
1 · Reply
Doctor_C_MD
Doctor_C_MD Aug. 23 at 1:47 AM
$HUMA Just a word of caution. I have been invested in this stock for nearly 3 years. I check this board routinely. Of all the people posting bearish posts and panicking over the last 1-2 weeks. This is the first time I have seen 90% of them in 3 years. Most likely that a majority of them are paid stock bashers.
0 · Reply
JuniperLuna
JuniperLuna Aug. 22 at 7:06 PM
$HUMA I recommend Laura divorce Dougan. Just a suggestion. NFA.
1 · Reply
Akwaba76
Akwaba76 Aug. 22 at 5:29 PM
$HUMA you don't need shorters when you got someone like Doug in the BOD
1 · Reply
paulN98
paulN98 Aug. 22 at 4:54 PM
$HUMA so sad, this stock was trading at 1.75-1.80 post earnings and was literally on its way back to 2 until dougy dumped
1 · Reply
Musky49
Musky49 Aug. 22 at 3:39 PM
$HUMA Thx Dougy you douche
0 · Reply
JinwooBuffett
JinwooBuffett Aug. 22 at 1:44 PM
$HUMA Here is that wardocs podcast with Dr.Sokolov in ukraine discussing the use of symvess to save lives. Just dropped! https://youtu.be/JfFfB4m-xII?si=2CrCZ_gM33oQNNqn
5 · Reply
charlie_twits
charlie_twits Aug. 22 at 10:41 AM
$HUMA https://www.panabee.com/news/humacyte-earnings-q2-2025-report?
0 · Reply
Addismr
Addismr Aug. 22 at 3:26 AM
$HUMA I wonder if Gordon Binder regrets buying 100,000 shares at $6.67 last May.
1 · Reply
Moski111
Moski111 Aug. 21 at 7:55 PM
$HUMA when the bears leave. The bulls will run 🤩
0 · Reply
jayed09
jayed09 Aug. 21 at 5:47 PM
$HUMA Im not selling!!!! either this go down to zero or 100!!
0 · Reply
mike711912
mike711912 Aug. 21 at 4:14 PM
$HUMA It is all about sentiment right now. It should be better. However, insiders selling was the wrong signal to send. That being said. I am looking forward to a recovery and possibly and exit for me in about 15 to 20 days from now.
1 · Reply
crowbaby333
crowbaby333 Aug. 21 at 3:54 PM
$HUMA
0 · Reply
fishtail69
fishtail69 Aug. 21 at 3:47 PM
$HUMA at this point they probably need to fire the ceo lol
2 · Reply
Stlcardsfan50
Stlcardsfan50 Aug. 21 at 3:47 PM
$HUMA which pumper bot farm are you from - Zimbabwe or Pakistan?
1 · Reply
Stlcardsfan50
Stlcardsfan50 Aug. 21 at 3:46 PM
$HUMA lmfao says the pumper bot account that’s getting killed and looking for even dumber retail to sell to 🤦‍♂️
1 · Reply
Jonjon1234
Jonjon1234 Aug. 21 at 3:44 PM
$HUMA Dugan and L.M. both sold shares because of his debts. Attn BOD it’s enough already. Shareholders should demand for a new experienced medtech CEO and for L.M. to move CSO.
0 · Reply